Variant report
Variant | nsv1026791 |
---|---|
Chromosome Location | chr7:15146654-15167158 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000111846 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142049250 | chr7:15146675-15146676 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs559256620 | chr7:15146709-15146710 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs182366500 | chr7:15146712-15146713 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs551455110 | chr7:15146717-15146718 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs185493159 | chr7:15146722-15146723 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs143226016 | chr7:15146773-15146774 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs550245227 | chr7:15146782-15146783 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs570311206 | chr7:15146796-15146797 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs535696477 | chr7:15146799-15146800 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs56404771 | chr7:15146814-15146815 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs565896994 | chr7:15146851-15146852 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs146726369 | chr7:15146897-15146898 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs557829158 | chr7:15146919-15146920 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs577659271 | chr7:15146926-15146927 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs140366012 | chr7:15146949-15146950 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs540174716 | chr7:15146987-15146988 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs377526593 | chr7:15147014-15147015 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs369984317 | chr7:15147059-15147060 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs56190216 | chr7:15147088-15147089 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs574003494 | chr7:15159220-15159221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143027334 | chr7:15159222-15159223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575818595 | chr7:15159299-15159300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189334469 | chr7:15159300-15159301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371098271 | chr7:15159349-15159350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551269430 | chr7:15159397-15159398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565353195 | chr7:15159411-15159412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372518850 | chr7:15159420-15159421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574029658 | chr7:15159442-15159443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375550864 | chr7:15159446-15159447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145253410 | chr7:15159448-15159449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113155933 | chr7:15159466-15159467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551013247 | chr7:15159482-15159483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1547963 | chr7:15159483-15159484 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs530020969 | chr7:15159504-15159505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369956580 | chr7:15159557-15159558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77420188 | chr7:15159567-15159568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs75200614 | chr7:15159568-15159569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs78868924 | chr7:15159571-15159572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373198480 | chr7:15159572-15159573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191766810 | chr7:15159574-15159575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566591944 | chr7:15159651-15159652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs538812481 | chr7:15159696-15159697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552014082 | chr7:15159697-15159698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs367932211 | chr7:15159702-15159703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184185306 | chr7:15159717-15159718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537506925 | chr7:15159733-15159734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79562804 | chr7:15159736-15159737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574090064 | chr7:15159744-15159745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372154819 | chr7:15159768-15159769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553613052 | chr7:15159769-15159770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:15159200-15160000 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr7:15160000-15164000 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr7:15162400-15163800 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr7:15162800-15163800 | Enhancers | HUVEC | blood vessel |
5 | chr7:15163000-15163400 | Enhancers | Fetal Heart | heart |
6 | chr7:15163400-15169400 | Weak transcription | Fetal Heart | heart |
7 | chr7:15163600-15164000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr7:15163800-15164000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr7:15163800-15164800 | Weak transcription | HUVEC | blood vessel |
10 | chr7:15164000-15164400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr7:15164000-15164400 | Enhancers | Placenta Amnion | Placenta Amnion |
12 | chr7:15164000-15166000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr7:15164000-15167800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr7:15164400-15167000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
15 | chr7:15164400-15169200 | Weak transcription | Placenta Amnion | Placenta Amnion |
16 | chr7:15164800-15165000 | Enhancers | HUVEC | blood vessel |
17 | chr7:15165000-15165400 | Weak transcription | HUVEC | blood vessel |
18 | chr7:15165400-15167200 | Enhancers | HUVEC | blood vessel |
19 | chr7:15166000-15166200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr7:15166200-15167600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr7:15167000-15167800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |